Dermata Therapeutics Inc (DRMA)

Currency in USD
5.2900
-0.2100(-3.82%)
Closed·

DRMA Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell

Technical Indicators

Strong Sell

Moving Averages

Sell

Summary:Strong Sell

Moving Averages:SellBuy: (1)Sell: (11)
Technical Indicators:Strong SellBuy: (0)Sell: (10)

Technical Indicators

Summary: Strong SellBuy: 0Neutral: 0Sell: 10
Aug 28, 2025 06:05 GMT
Name
Value
Action
RSI(14)41.142Sell
STOCH(9,6)28.452Sell
STOCHRSI(14)20.279Oversold
MACD(12,26)-0.108Sell
ADX(14)52.751Sell
Williams %R-78.583Sell
CCI(14)-98.881Sell
ATR(14)0.1689Less Volatility
Highs/Lows(14)-0.1308Sell
Ultimate Oscillator39.923Sell
ROC-9.262Sell
Bull/Bear Power(13)-0.2821Sell

Moving Averages

Summary: SellBuy: 1Sell: 11
Aug 28, 2025 06:05 GMT
Name
Simple
Exponential
MA5
5.2621
Buy
5.3131
Sell
MA10
5.3790
Sell
5.3988
Sell
MA20
5.5918
Sell
5.4637
Sell
MA50
5.6092
Sell
5.6604
Sell
MA100
6.0036
Sell
5.9227
Sell
MA200
6.4362
Sell
6.2118
Sell

Pivot Points

Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic5.35.35.35.35.35.35.3
Fibonacci5.35.35.35.35.35.35.3
Camarilla5.35.35.35.35.35.35.3
Woodie's5.35.35.35.35.35.35.3
DeMark's--5.35.35.3--

FAQ

From a Technical Analysis Perspective, Is Dermata Therapeutics a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Do the Moving Averages for DRMA Currently Stand?

The moving averages for Dermata Therapeutics show a Sell outlook, considering moving averages ranging from MA5 to MA200, with 1 Buy signals and 11 Sell signals.

What Is the Current Status of the Technical Indicators for Dermata Therapeutics?

The technical indicators for Dermata Therapeutics are in a Strong Sell position based on daily analysis, with 0 signals on buy indicators and 8 sell signals.

What Is DRMA's 14-Day RSI?

The current Relative Strength Index (RSI) of DRMA over the 14-day period is 41.142, which suggests that the stock is a Sell.

What Is DRMA's MACD?

DRMA's MACD is -0.108, which suggests that the stock is a Sell.

What Is DRMA's 5-Day Moving Average?

DRMA's 5-day moving average is 5.2621, suggesting that the stock is a Buy.

What Is DRMA's 50-Day Moving Average?

DRMA's 50-day moving average is 5.6092, suggesting that the stock is a Sell.

What Is DRMA's 200-Day Moving Average?

DRMA's 200-day moving average is 6.4362, suggesting that the stock is a Sell.

What Is the Fibonacci Pivot Point Performance Value for DRMA?

The Fibonacci pivot point performance value for DRMA is 5.3000.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.